GPT and Hepatic fibrosis: Based on the selected risk factor combinations for the Finnish dataset, the presence of any one of these risk factors could be a prompter in screening programs to further assess for advanced liver fibrosis by FIB-4 or similar tests: alcohol use >210 (men)/140 (women) g/week, at least 3 metabolic components, BMI ≥35 kg/m2, intermediate–high CLivD score, and AST:ALT ratio >0.8 with elevated ALT levels.